References
- Global Perspectives on Hepatitis. Newsletter of the International Task Force on Hepatitis B Immunization and the Programme for Appropriate Technology in Health (PATH) 1993;4:3–10.
- World Health Organisation (WHO) (1992). Informal discussion on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine. Final report. Geneva: WHO 1992:1–12.
- Usonis V, Bakasenas V, Willems P, Clemens R. Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune response with diphtheria-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as mixed or injected into separate limbs. Vaccine 1997; 15: 1680–6
- Kanra G, Ceyhan M, Ecevit Z, Bogaerts H. Primary vaccination of infants with a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine. Pediatr Infect Dis J 1995; 14: 998–9
- Recommendations of the Advisory Committee on Immunization Practices (ACIP). Update of vaccine side-effects, adverse reactions, contraindications and precautions. Morbidity and Mortality Weekly Report 1996;45:1–35.
- Zepp F, Schuind A, Meyer C, Sänger R, Kaufhold A, Willems P. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics 2002; 109: 58
- Yeh SH, Ward JI, Partridge S, Marcy SM, Lee H, Jing J, et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr Infect Dis J 2001; 20: 973–80
- Camargo ME, Silveira L, Fututa JA, Oliveira EPT, Germek OA. Immunoenzymatic assay of anti-diphtheria toxin antibodies in human serum. J Clin Microbiol 1984; 20: 772–4
- Manghi MA, Pasetti MF, Brero ML. Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the tetanus neutralization test in mice. J Immunol Meth 1994; 168: 17–27
- Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of an enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983; 11: 137–44
- Melville-Smith ME, Balfour A. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralization test. J Med Microbiol 1988; 25: 279–83
- Standard procedure for determining immunity to poliovirus using the microneutralization test (WHO/EPI/Gen 93.3).
- Granström M, Thoeren M, Tiru M, Sato Y. Acellular pertussis vaccine in adults: adverse reactions and immune response. Eur J Clin Microbiol 1987; 6: 18–21
- Kanra G, Ceyhan M, Bogaerts H, Vandervoode D. Acellular pertussis vaccine containing separately purified PT, FHA and 69 kDa OMP as a booster in children. Eur J Pediatr 1993; 152: 478–83
- van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT. Natural history of pertussis antibody in the infant and the effect of vaccine response. J Infect Dis 1990; 161: 487–92
- Gylca R, Gylca V, Benes O, Melnic A, Chicu V, Weisbecker C, et al. A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. Vaccine 2001; 19: 825–33
- Hellwig SM, Rodriguez ME, Berbers GA, van de Winkel JG, Mooi FR. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 2003; 188: 738–42
- Schmitt HJ, Knuf M, Ortiz E, Sänger R, Uwamwezi MC, Kaufhold A. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type B vaccines given as either separate or mixed injections. J Pediatrics 2000; 137: 304–12
- Pichichero ME, Francis AB, Marsocci SM, Green JL, Disney FA, Meschievitz C, et al. Safety and immunogenicity of an acellular pertussis booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine as infants. Pediatrics 1993; 91: 756–60
- Halperin SA, Mills E, Barreto L, Pim C, Eastwood BJ. Acellular pertussis vaccine as a booster dose for 17- to 19-month-old children immunized with either whole cell or acellular pertussis vaccine at 2, 4 and 6 months of age. Pediatr Infect Dis J 1995; 14: 792–7
- Meriste S, Tamm E, Willems P, Lutsar I. Safety and immunogenicity of combined DTPa-IPV vaccine for primary and booster vaccination. Scand J Infect Dis 1999; 31: 587–91